Biologic license application

From Infogalactic: the planetary knowledge core
Jump to: navigation, search

A biologics license application (BLA) is defined by the U.S. Food and Drug Administration (FDA) as follows:

The Biologics License Application (BLA) is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2). The BLA is regulated under 21 CFR 600 – 680. A BLA is submitted by any legal person or entity who is engaged in manufacture or an applicant for a license who takes responsibility for compliance with product and establishment standards. Form 356h specifies the requirements for a BLA. This includes:

  • Applicant information
  • Product/Manufacturing information
  • Pre-clinical studies
  • Clinical studies
  • Labeling

Reference: http://www.fda.gov/BiologicsBloodVaccines/DevelopmentApprovalProcess/BiologicsLicenseApplicationsBLAProcess/

Biological product vs. biologic vs. biologics

Throughout the FDA web site,[1] literature,[2] and Wikipedia,[3] the following variations of the term are used.

  • Biologics license application
  • Biologic license application
  • Biological license application
  • Biological product license application

Per 21 CFR 601, the official term utilized is "biologics license application."

This article uses the word "biologic" for the following reasons:

  1. It is the more common shorter form used for the expression "biological product".
  2. "Biological product license application" has regulatory weight because it is used in the Federal Register,[4] but it is seldom used anywhere else.
  3. Nouns used as modifiers in compound nouns are not traditionally considered grammatically correct in the plural (e.g. "two-car garage") unless the singular would have a different meaning (e.g. "arms race").
  4. It is the term used in the heading of the FDA's glossary entry[5] (although within the entry, it uses "biologics" — see the quoted definition above.)
  5. It is the term used on the actual form, which is titled "APPLICATION TO MARKET A NEW DRUG, BIOLOGIC, OR AN ANTIBIOTIC DRUG FOR HUMAN USE"[6]

See also

References

<templatestyles src="Reflist/styles.css" />

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
  1. FDA web site search results for "Biologic License Application". Accessed 07 July 2010.
  2. Google search results for "Biologic License Application". Accessed 07 July 2010.
  3. Wikipedia web site search results for "Biologic License". Accessed 07 July 2010.
  4. Federal Register (Vol. 62, No. 16, Friday, January 24, 1997), pp. 3703-3704.
  5. FDA: Drugs@FDA Glossary of Terms, "Biologic License Application (BLA)". Accessed 07 July 2010.
  6. FDA: FORM FDA 356h (10/05), "APPLICATION TO MARKET A NEW DRUG, BIOLOGIC, OR AN ANTIBIOTIC DRUG FOR HUMAN USE". Accessed 07 July 2010.